on Sonnet BioTherapeutics, Inc. (NASDAQ:SONN)
Sonnet BioTherapeutics to Present at EF Hutton Annual Global Conference
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN), a biopharmaceutical company specializing in targeted biologic drugs, announced its participation in the EF Hutton Annual Global Conference. This event is scheduled for May 15, 2024, at The Plaza Hotel in New York. Pankaj Mohan, Ph.D., the company's founder and CEO, along with Richard Kenney, M.D., Chief Medical Officer, and Jay Cross, Chief Financial Officer, will represent Sonnet at the conference on May 15th.
During the conference, the management team from Sonnet BioTherapeutics will also engage in one-on-one investor meetings throughout the day. Individuals interested in attending can register for the event online. This participation underscores Sonnet's commitment to advancing its position in the biopharmaceutical industry through its innovative biologic drugs and proprietary technologies.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Sonnet BioTherapeutics, Inc. news